Biodesix (NASDAQ:BDSX – Get Rating) and Invitae (NYSE:NVTA – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, analyst recommendations, profitability, earnings and valuation. Institutional & Insider Ownership 76.8% of Invitae shares are held by […]
Shares of Invitae Co. (NYSE:NVTA – Get Rating) have earned an average rating of “Hold” from the twelve analysts that are currently covering the stock, Marketbeat Ratings reports. Five investment analysts have rated the stock with a sell recommendation and six have issued a hold recommendation on the company. The average twelve-month price target among […]
Invitae Co. (NYSE:NVTA – Get Rating) has received a consensus rating of “Hold” from the twelve research firms that are presently covering the company, MarketBeat.com reports. Five investment analysts have rated the stock with a sell recommendation and six have assigned a hold recommendation to the company. The average twelve-month price target among brokers that […]
Invitae Co. (NYSE:NVTA – Get Rating) has been assigned an average recommendation of “Hold” from the twelve brokerages that are presently covering the company, Marketbeat.com reports. Five investment analysts have rated the stock with a sell recommendation and six have assigned a hold recommendation to the company. The average 12 month price objective among analysts […]
SG Americas Securities LLC raised its holdings in shares of Invitae Co. (NYSE:NVTA – Get Rating) by 177.6% in the 3rd quarter, HoldingsChannel reports. The firm owned 138,631 shares of the medical research company’s stock after buying an additional 88,688 shares during the period. SG Americas Securities LLC’s holdings in Invitae were worth $341,000 as […]